跳至主要内容
临床试验/JPRN-UMIN000031835
JPRN-UMIN000031835招募中未知

The efficacy of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for cis-platinum intolerant high-risk head and neck cancer patients. - The efficacy of postoperative B-CRT using Cmab and DTX for CDDP intolerant high-risk head and neck cancer patients.

Yokohama City University Hospital0 个研究点目标入组 35 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Prior to enrollment in this trial, the patients must not meet any of the following criteria: uncurable synchronous malignancies, priority systemic diseases, and refusal to undergo the definitive surgery and/or postoperative radiotherapy.

研究者

相似试验

进行中(未招募)
1 期
clinical study to evaluate the efficacy of a two drug combination versus a single drug therapy in the treatment of locally advanced rectal cancer.locally advanced rectal cancerMedDRA version: 17.0Level: PTClassification code 10038050Term: Rectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-006532-21-DEEORTC1,094
进行中(未招募)
不适用
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancerRectal cancerLocally Advanced Rectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12608000403336Australasian Gastro-Intestinal Trials Group (AGITG)1,090
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1Level: LLTClassification code 10038050Term: Rectal cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10038049Term: Rectal cancer stage II
EUCTR2006-006532-21-FREORTC1,090
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1 Level: LLT Classification code 10038050 Term: Rectal cancer stage IIIMedDRA version: 9.1 Level: LLT Classification code 10038049 Term: Rectal cancer stage II
EUCTR2006-006532-21-GBEuropean Organization for Research and Treatment of Cancer1,094
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6)locally advanced rectal cancerMedDRA version: 14.1Level: PTClassification code 10038050Term: Rectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-006532-21-BEEORTC1,090